Ann Arbor Company, Millendo Therapeutics, Sets Michigan Record by Raising $62 Million

Millendo Therapeutics, Inc., today announced that it has entered into an exclusive license agreement with AstraZeneca for the worldwide development and commercialization rights to AZD4901, a product candidate for the treatment of polycystic ovary syndrome (PCOS), the most common endocrine disease in women. The Company will develop the compound as MLE4901. In addition, Millendo has …

Read more Ann Arbor Company, Millendo Therapeutics, Sets Michigan Record by Raising $62 Million

Nine Companies Receive Michigan Microloan Fund Program Support

Nine Michigan companies have received a combined total of more than $478,000 through the Michigan Microloan Fund Program, bringing the total amount invested through the Fund to more than $2 million.  The companies received the funding to support commercialization of their core products. “Microloan funding, by design, is that bit of extra support that a company needs …

Read more Nine Companies Receive Michigan Microloan Fund Program Support